60 related articles for article (PubMed ID: 21635855)
1. Fluconazole population pharmacokinetics and dosing for prevention and treatment of invasive Candidiasis in children supported with extracorporeal membrane oxygenation.
Watt KM; Gonzalez D; Benjamin DK; Brouwer KL; Wade KC; Capparelli E; Barrett J; Cohen-Wolkowiez M
Antimicrob Agents Chemother; 2015 Jul; 59(7):3935-43. PubMed ID: 25896706
[TBL] [Abstract][Full Text] [Related]
2. Population pharmacokinetic analysis of fluconazole to predict therapeutic outcome in burn patients with Candida infection.
Han S; Kim J; Yim H; Hur J; Song W; Lee J; Jeon S; Hong T; Woo H; Yim DS
Antimicrob Agents Chemother; 2013 Feb; 57(2):1006-11. PubMed ID: 23254425
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients.
Bellmann R; Smuszkiewicz P
Infection; 2017 Dec; 45(6):737-779. PubMed ID: 28702763
[TBL] [Abstract][Full Text] [Related]
4. Tolerability of long-term fluconazole therapy.
Davis MR; Nguyen MH; Donnelley MA; Thompson Iii GR
J Antimicrob Chemother; 2019 Mar; 74(3):768-771. PubMed ID: 30535104
[TBL] [Abstract][Full Text] [Related]
5. Clinical pharmacokinetics of fluconazole in superficial and systemic mycoses.
Debruyne D
Clin Pharmacokinet; 1997 Jul; 33(1):52-77. PubMed ID: 9250423
[TBL] [Abstract][Full Text] [Related]
6. [Level of evidence for therapeutic drug monitoring of posaconazole].
Lefeuvre S; Jelassi ML; Benlmouden A; Berge M; Le Guellec C; Billaud EM;
Therapie; 2011; 66(2):115-22. PubMed ID: 21635858
[TBL] [Abstract][Full Text] [Related]
7. Fluconazole: a new antifungal agent.
Kowalsky SF; Dixon DM
Clin Pharm; 1991 Mar; 10(3):179-94. PubMed ID: 2040125
[TBL] [Abstract][Full Text] [Related]
8. [Level of evidence for therapeutic drug monitoring of fluconazole].
Venisse N; Le Guellec C
Therapie; 2011; 66(2):97-101. PubMed ID: 21635855
[TBL] [Abstract][Full Text] [Related]
9. [Level of evidence for therapeutic drug monitoring of itraconazole].
Charles M; Le Guellec C; Richard D; Libert F;
Therapie; 2011; 66(2):103-8. PubMed ID: 21635856
[TBL] [Abstract][Full Text] [Related]
10. [Level of evidence for therapeutic drug monitoring of voriconazole].
Hulin A; Dailly E; Le Guellec C;
Therapie; 2011; 66(2):109-14. PubMed ID: 21635857
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
